Compare
InspireMD, Inc. vs Neuroone Medical Technologies Corp vs WORK Medical Technology Group LTD vs Beyond Air, Inc.
| Latest fiscal year | InspireMD, Inc. NSPR | Neuroone Medical Technologies Corp NMTC | WORK Medical Technology Group LTD WOK | Beyond Air, Inc. XAIR |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-09-30 | 2025-09-30 | 2026-03-31 |
| Revenue | $8.98M | $9.10M | $9.85M | $7.68M |
| Revenue growth (YoY) | +28.1% | +163.5% | -14.4% | +107.3% |
| Gross margin | 29.5% | 56.5% | 23.8% | 3.3% |
| Operating margin | -552.6% | -46.5% | n/a | -378.2% |
| Net margin | -543.3% | -39.6% | -10.9% | -433.0% |
| Net income | -$48.79M | -$3.61M | -$1.07M | -$33.25M |
| EPS (Diluted) | -$0.76 | -$0.09 | -$0.04 | -$4.01 |
| Operating cash flow | -$35.10M | -$2.84M | $6.24M | -$18.14M |
| Free cash flow | -$36.77M | -$2.92M | $4.91M | -$19.17M |
| Cash & equivalents | $8.94M | $6.57M | $4.09M | $6.74M |
| Total assets | $69.40M | $10.79M | $33.16M | $35.38M |
| Total liabilities | $14.20M | $3.71M | $11.99M | $29.18M |
| Shareholders' equity | $55.20M | $7.07M | $21.16M | $6.13M |
| Return on year-end equity | -88.4% | -51.0% | -5.1% | -542.8% |
| Shares outstanding | 43.53M | 50.01M | n/a | 11.79M |
Revenue, most recent five fiscal years
| Fiscal year | InspireMD, Inc. | Neuroone Medical Technologies Corp | WORK Medical Technology Group LTD | Beyond Air, Inc. |
|---|---|---|---|---|
| Latest | $8.98M Ended 2025-12-31 | $9.10M Ended 2025-09-30 | $9.85M Ended 2025-09-30 | $7.68M Ended 2026-03-31 |
| 1 year earlier | $7.01M Ended 2024-12-31 | $3.45M Ended 2024-09-30 | $11.51M Ended 2024-09-30 | $3.71M Ended 2025-03-31 |
| 2 years earlier | $6.21M Ended 2023-12-31 | $1.95M Ended 2023-09-30 | $13.57M Ended 2023-09-30 | $1.16M Ended 2024-03-31 |
| 3 years earlier | $5.17M Ended 2022-12-31 | $171.2K Ended 2022-09-30 | $19.71M Ended 2022-09-30 | n/a |
| 4 years earlier | $4.50M Ended 2021-12-31 | $178.1K Ended 2021-09-30 | n/a | n/a |